Literature DB >> 30521417

Circlular RNA BARD1 (Hsa_circ_0001098) overexpression in breast cancer cells with TCDD treatment could promote cell apoptosis via miR-3942/BARD1 axis.

Jianzhu Zhao1, Huawei Zou1, Chengbo Han1, Jietao Ma1, Jungang Zhao2, Jun Tang2.   

Abstract

Breast cancer threatened the health of millions of people around the world. Here we explored the influence of TCDD on the expression of circRNA_BARD1 (circ_0001098) in breast cancer and studied the potential molecular mechanism of circRNA_BARD1. The data from GSE76608 was applied to analyze differentially expressed circRNAs and mRNAs. The expressions of circRNA_BARD1, BARD1, miR-3942-3p, miR-4760-3p and apoptosis-related protein p53 were detected by qRT-PCR or western blot. Circinteractome, TargetScan, CIRCNET and dual luciferase reporter assay were employed to uncover the target relationship between circRNA_BARD1/BARD1 and miR-3942-3p/miR-4760-3p. Flow cytometric analysis was used to reveal cell cycle and cell apoptosis. Immunofluorescence was applied to determinate γ-H2AX level. Xenograft assay and in vivo 3-D imaging was implemented to further verify the conclusions in vitro. CircRNA_BARD1 (circ_0001098) was up-regulated in breast cancer with the treatment of TCDD and the up-regulation of circRNA_BARD1 could restrain cell proliferation, block cell cycle and promote cell apoptosis. Moreover, the target relationship between circRNA_BARD1/BARD1 and miR-3942-3p was confirmed. In addition, miR-3942-3p overexpression promoted the disease progression and BARD1 up-regulation inhibited the disease progression in the breast cancer. Similarly, circRNA_BARD1 overexpression induced by TCDD suppressed the growth and metastasis of tumor in vivo. In conclusion, TCDD induced circ_0001098 overexpression and then suppressed breast cancer tumorigenesis via miR-3942-3p/BARD1 axis. The finding of TCDD-circRNA-miRNA-mRNA axis might bring a new perspective for cure strategy of breast cancer.

Entities:  

Keywords:  BARD1; Breast cancer; CircRNA_BARD1 (circ_0001098); MiR-3942-3p; TCDD

Mesh:

Substances:

Year:  2018        PMID: 30521417      PMCID: PMC6343738          DOI: 10.1080/15384101.2018.1556058

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  25 in total

Review 1.  miRNA dysregulation in breast cancer.

Authors:  Laoighse Mulrane; Sharon F McGee; William M Gallagher; Darran P O'Connor
Journal:  Cancer Res       Date:  2013-11-07       Impact factor: 12.701

2.  Progesterone receptor is involved in 2,3,7,8-tetrachlorodibenzo-p-dioxin-stimulated breast cancer cells proliferation.

Authors:  Yun-Ju Chen; Chao-Ming Hung; Nari Kay; Chin-Chen Chen; Ying-Hsien Kao; Shyng-Shiou Yuan
Journal:  Cancer Lett       Date:  2012-01-18       Impact factor: 8.679

3.  BARD1 splice variants display mislocalization in breast cancer cells and can alter the apoptotic response to cisplatin.

Authors:  Kamila A Marzec; Estefania Martino-Echarri; Irmgard Irminger-Finger; Beric R Henderson
Journal:  Cancer Lett       Date:  2016-07-28       Impact factor: 8.679

4.  BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes.

Authors:  Mikaela D Stewart; Elena Zelin; Abhinav Dhall; Tom Walsh; Esha Upadhyay; Jacob E Corn; Champak Chatterjee; Mary-Claire King; Rachel E Klevit
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-24       Impact factor: 11.205

5.  Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells.

Authors:  Shu Zhang; KyoungHyun Kim; Un Ho Jin; Catherine Pfent; Huojun Cao; Brad Amendt; Xinyi Liu; Heather Wilson-Robles; Stephen Safe
Journal:  Mol Cancer Ther       Date:  2011-10-27       Impact factor: 6.261

6.  Involvement of microRNAs in dioxin-induced liver damage in the mouse.

Authors:  Wataru Yoshioka; Wataru Higashiyama; Chiharu Tohyama
Journal:  Toxicol Sci       Date:  2011-05-20       Impact factor: 4.849

7.  Possible aryl hydrocarbon receptor-independent pathway of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced antiproliferative response in human breast cancer cells.

Authors:  Hiroki Yoshioka; Youhei Hiromori; Akira Aoki; Tomoki Kimura; Yoshiaki Fujii-Kuriyama; Hisamitsu Nagase; Tsuyoshi Nakanishi
Journal:  Toxicol Lett       Date:  2012-04-15       Impact factor: 4.372

8.  Evaluation of human epidermal growth factor receptor 2 (HER2) single nucleotide polymorphisms (SNPs) in normal and breast tumor tissues and their link with breast cancer prognostic factors.

Authors:  Daniela Furrer; Julie Lemieux; Marc-André Côté; Louise Provencher; Christian Laflamme; Frédéric Barabé; Simon Jacob; Annick Michaud; Caroline Diorio
Journal:  Breast       Date:  2016-10-24       Impact factor: 4.380

Review 9.  CircRNA: a novel type of biomarker for cancer.

Authors:  He-da Zhang; Lin-Hong Jiang; Da-Wei Sun; Jun-Chen Hou; Zhen-Ling Ji
Journal:  Breast Cancer       Date:  2017-07-18       Impact factor: 4.239

10.  Compendium of TCDD-mediated transcriptomic response datasets in mammalian model systems.

Authors:  Stephenie D Prokopec; Kathleen E Houlahan; Ren X Sun; John D Watson; Cindy Q Yao; Jamie Lee; Christine P'ng; Renee Pang; Alexander H Wu; Lauren C Chong; Ashley B Smith; Nicholas J Harding; Ivy D Moffat; Jere Lindén; Sanna Lensu; Allan B Okey; Raimo Pohjanvirta; Paul C Boutros
Journal:  BMC Genomics       Date:  2017-01-13       Impact factor: 3.969

View more
  16 in total

Review 1.  Roles of circular RNA in breast cancer: present and future.

Authors:  Zehuan Li; Zhanghan Chen; Guohua Hu; Ying Jiang
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

Review 2.  Circular RNAs Interaction with MiRNAs: Emerging Roles in Breast Cancer.

Authors:  Liu Gong; XiaoYun Zhou; Jiping Sun
Journal:  Int J Med Sci       Date:  2021-07-11       Impact factor: 3.738

3.  The Regulation Network and Clinical Significance of Circular RNAs in Breast Cancer.

Authors:  Juan Xu; Xiyi Chen; Yu Sun; Yaqian Shi; Fang Teng; Mingming Lv; Chen Liu; Xuemei Jia
Journal:  Front Oncol       Date:  2021-07-09       Impact factor: 6.244

4.  Circular RNA circ-SLC7A6 acts as a tumor suppressor in non-small cell lung cancer through abundantly sponging miR-21.

Authors:  Yuan Wang; Fushuang Zheng; Zibo Wang; Jibin Lu; Hongyan Zhang
Journal:  Cell Cycle       Date:  2020-08-14       Impact factor: 4.534

Review 5.  The Emerging Role of MicroRNAs in Breast Cancer.

Authors:  Zhiguang Yang; Zhaoyu Liu
Journal:  J Oncol       Date:  2020-07-03       Impact factor: 4.375

6.  Upregulated Circular RNA circ-UBE2D2 Predicts Poor Prognosis and Promotes Breast Cancer Progression by Sponging miR-1236 and miR-1287.

Authors:  Yan Wang; Jingruo Li; Chuang Du; Linfeng Zhang; Yingying Zhang; Jianhua Zhang; Liuxing Wang
Journal:  Transl Oncol       Date:  2019-07-20       Impact factor: 4.243

7.  Progress of research into circular RNAs in urinary neoplasms.

Authors:  Bangbei Wan; Bo Liu; Cai Lv
Journal:  PeerJ       Date:  2020-02-24       Impact factor: 2.984

8.  Identification of breast cancer-related circRNAs by analysis of microarray and RNA-sequencing data: An observational study.

Authors:  Chun-Hua Zhao; Le Qu; Hui Zhang; Rui Qu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 9.  Recent Discoveries of Macromolecule- and Cell-Based Biomarkers and Therapeutic Implications in Breast Cancer.

Authors:  Hsing-Ju Wu; Pei-Yi Chu
Journal:  Int J Mol Sci       Date:  2021-01-10       Impact factor: 5.923

10.  A novel circRNA-miRNA-mRNA network reveals hsa-circ-0040039 as a biomarker for intervertebral disc degeneration.

Authors:  Jianhua Tang; Chenlin Zhang; Shengru Wang; Jianfeng Chen
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.